Reduced density of glutamine synthetase immunoreactive astrocytes in different cortical areas in major depression but not in bipolar I disorder

Frontiers in Cellular Neuroscience

Volumn 9, Issue AUGUST, 2015, Pages

  Bernstein, Hans Gert ^a   Meyer Lotz, Gabriela ^a   Dobrowolny, Henrik ^a   Bannier, Jana ^a   Steiner, Johann ^a   Walter, Martin ^a   Bogerts, Bernhard ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Astroglia; Bipolar disorder; Cortex; Glutamine synthetase; Immunocytochemistry; Major depression; Oligodendroglia

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; CARBAMAZEPINE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE AMMONIA LIGASE; LITHIUM; NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; ASTROCYTE; BIPOLAR I DISORDER; BRAIN CORTEX; CELL COUNTING; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLIA CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR DEPRESSION; MALE; MIDDLE AGED; OLIGODENDROGLIA;

EID: 84940203801     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2015.00273     Document Type: Article

References (85)

1. Altshuler, L. L., Abulseoud, O. A., Foland-Ross, L., Bartzokis, G., Chang, S., Mintz, J., et al. (2010). Amygdala astrocyte reduction in subjects with major depression but not bipolar disorder. Bipolar Disord. 1, 451-549. doi: 10.1111/j.1399-5618.2010.00838.x
2. Anlauf, E., and Derouiche, A. (2013). Glutamine synthetase as an astrocytic marker: its cell type and vesicle localization. Front. Endocrinol. 4:144. doi: 10.3389/fendo.2013.00144
3. Arnone, D., Mumuni, A. N., Jauhar, S., Condon, B., and Cavanagh, J. (2015). Indirect evidence of selective glial involvement in glutamate-based mechanisms of mood regulation in depression: meta-analysis of absolute prefrontal neuro-metabolic concentrations. Eur. Neuropsychopharmacol. doi: 10.1016/j.euroneuro.2015.04.016 [Epub ahead of print].
4. Bajbouj, M., Lisanby, S. H., Lang, U. E., Danker-Hopfe, H., Heuser, I., and Neu, P. (2006). Evidence for impaired cortical inhibition in patients with unipolar major depression. Biol. Psychiatry 59, 395-400. doi: 10.1016/j.biopsych.2005.07.036
5. Barley, K., Dracheva, S., and Byne, W. (2009). Subcortical oligodendrocyte-and astrocyte-associated gene expression in subjects with schizophrenia, major depression and bipolar disorder. Schizophr. Res. 112, 54-64. doi: 10.1016/j.schres.2009.04.01
6. Beasley, C. L., Pennington, K., Behan, A., Wait, R., Dunn, M. J., and Cotter, D. (2006). Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: evidence for disease-associated changes. Proteomics 6, 3414-3425. doi: 10.1002/pmic.200500069
7. Bernstein, H. G., Bannier, J., Meyer-Lotz, G., Steiner, J., Keilhoff, G., Dobrowolny, H., et al. (2014). Distribution of immunoreactive glutamine synthetase in the adult human and mouse brain. Qualitative and quantitative observations with special emphasis on extra-astroglial protein localization. J. Chem. Neuroanat. 61-62, 33-50. doi: 10.1016/j.jchemneu.2014.07.003
8. Bernstein, H. G., Krell, D., Baumann, B., Danos, P., Falkai, P., Diekmann, S., et al. (1998a). Morphometric studies of the entorhinal cortex in neuropsychiatric patients and controls: clusters of heterotopically displaced lamina II neurons are not indicative of schizophrenia. Schizophr. Res. 33, 125-132. doi: 10.1016/S0920-9964(98)00071-1
9. Bernstein, H. G., Stanarius, A., Baumann, B., Henning, H., Krell, D., Danos, P., et al. (1998b). Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics. Neuroscience 83, 867-875. doi: 10.1016/S0306-4522(97)00461-2
10. Bernstein, H. G., Steiner, J., Guest, P. C., Dobrowolny, H., and Bogerts, B. (2015). Glial cells as key players in schizophrenia pathology: recent insights and concepts of therapy. Schizophr. Res. 161, 4-18. doi: 10.1016/j.schres.2014.03.035
11. Bernstein, H. G., Tausch, A., Wagner, R., Steiner, J., Seeleke, P., Walter, M., et al. (2013). Disruption of glutamate-glutamine-GABA cycle significantly impacts on suicidal behaviour: survey of the literature and own findings on glutamine synthetase.CNS Neurol. Disord. Drug Targets 12, 900-913. doi: 10.2174/18715273113129990091
12. Bewernick, B. H., Kayser, S., Sturm, V., and Schlaepfer, T. E. (2012). Long-term effects of nucleus accumbens deep brain stimulation in treatment-resistant depression: evidence for sustained efficacy. Neuropsychopharmacology 37, 1975-1985. doi: 10.1038/npp.2012.44
13. Bielau, H., Trübner, K., Krell, D., Agelink, M. W., Bernstein, H. G., Stauch, R., et al. (2005). Volume deficits of subcortical nuclei in mood disorders A postmortem study. Eur. Arch. Psychiatry Clin. Neurosci. 255, 401-412. doi: 10.1007/s00406-005-0581-y
14. Boksha, I. S., Tereshkina, E. B., and Burbaeva, G. S. (2000). Glutamine synthetase and glutamine synthetase-like protein from human brain: purification and comparative characterization. J. Neurochem. 75, 2574-2582. doi: 10.1046/j.1471-4159.2000.0752574.x
15. Brennan, B. P., Hudson, J. I., Jensen, J. E., McCarthy, J., Roberts, J. L., Prescot, A. P., et al. (2010). Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole. Neuropsychopharmacology 35, 834-846. doi: 10.1038/npp.2009.191
16. Burbaeva, G. S., Boksha, I. S., Tereshkina, E. B., Savushkina, O. K., Prokhorova, T. A., and Vorobyeva, E. A. (2014). Glutamate and GABA-metabolizing enzymes in post-mortem cerebellum in Alzheimer's disease: phosphate-activated glutaminase and glutamic acid decarboxylase. Cerebellum 13, 607-615. doi: 10.1007/s12311-014-0573-4
17. Burbaeva, G. S., Boksha, I. S., Turishcheva, M. S., Vorobyeva, E. A., Savushkina, O. K., and Tereshkina, E. B. (2003). Glutamine synthetase and glutamate dehydrogenase in the prefrontal cortex of patients with schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry. 27, 675-680. doi: 10.1016/S0278-5846(03)00078-2
18. Catena-Dell'Osso, M., Fagiolini, A., Rotella, F., Baroni, S., and Marazziti, D. (2013). Glutamate system as target for development of novel antidepressants. CNS Spectr. 18, 188-198. doi: 10.1017/S1092852912000971
19. Choudary, P. V., Molnar, M., Evans, S. J., Tomita, H., Li, J. Z., and Vawter, M. P. (2005). Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc. Natl. Acad. Sci. U.S.A. 102, 15653-15658. doi: 10.1073/pnas.0507901102
20. Cotter, D., Mackay, D., Chana, G., Beasley, C., Landau, S., and Everall, I. P. (2002). Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cereb. Cortex 12, 386-394. doi: 10.1093/cercor/12.4.386
21. Cotter, D., Mackay, D., Landau, S., Kerwin, R., and Everall, I. (2001a). Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch. Gen. Psychiatry 58, 545-553. doi: 10.1001/archpsyc.58.6.545
22. Cotter, D. R., Pariante, C. M., and Everall, I. P. (2001b). Glial cell abnormalities in major psychiatric disorders: the evidence and implications. Brain Res. Bull. 55, 585-595. doi: 10.1016/S0361-9230(01)00527-5
23. Couchman, J. R. (2009). Commercial antibodies: the good, bad, and really ugly. J. Histochem. Cytochem. 57, 7-8. doi: 10.1369/jhc.2008.952820
24. Davis, S., Thomas, A., Perry, R., Oakley, A., Kalaria, R. N., and O'Brien, J. T. (2002). Glial fibrillary acidic protein in late life major depressive disorder: an immunocytochemical study. J. Neurol. Neurosurg. Psychiatry 73, 556-560. doi: 10.1136/jnnp.73.5.556
25. Delgado, P. L. (2000). Depression: the case for a monoamine deficiency. J. Clin. Psychiatry 61(Suppl. 6), 7-11.
26. DeWilde, K. E., Levitch, C. F., Murrough, J. W., Mathew, S. J., and Iosifescu, D. V. (2015). The promise of ketamine for treatment-resistant depression: current evidence and future directions. Ann. N. Y. Acad. Sci. 1345, 47-58. doi: 10.1111/nyas.12646
27. Dong, X. H., and Zhen, X. C. (2015). Glial pathology in bipolar disorder: potential therapeutic implications. CNS Neurosci. Ther. 21, 393-397. doi: 10.1111/cns.12390
28. Dou, W., Palomero-Gallagher, N., van Tol, M. J., Kaufmann, J., Zhong, K., Bernstein, H. G., et al. (2013). Systematic regional variations of GABA, glutamine, and glutamate concentrations follow receptor fingerprints of human cingulate cortex. J. Neurosci. 33, 12698-12704. doi: 10.1523/JNEUROSCI.1758-13.20
29. Duman, R. S. (2014). Neurobiology of stress, depression, and rapid acting antidepressants: remodeling synaptic connections.Depress. Anxiety 31, 291-296. doi: 10.1002/da.22227
30. Duncan, L. E., Holmans, P. A., Lee, P. H., O'Dushlaine, C. T., Kirby, A. W., Smoller, J. W., et al. (2014). Pathway analyses implicate glial cells in schizophrenia. PLoS ONE 9:e89441. doi: 10.1371/journal.pone.0089441
31. Etiévant, A., Lambás-Señas, L., Scarna, H., Lucas, G., and Haddjeri, N. (2013). Astrocytes and gliotransmitters: new players in the treatment of major depression? Curr. Drug Targets 14, 1295-1307. doi: 10.2174/13894501113149990197
32. Fellin, T., D'Ascenzo, M., and Haydon, P. G. (2007). Astrocytes control neuronal excitability in the nucleus accumbens.ScientificWorldJournal 7, 89-97. doi: 10.1100/tsw.2007.195
33. Gigante, A. D., Bond, D. J., Lafer, B., Lam, R. W., Young, L. T., and Yatham, L. N. (2012). Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta-analysis. Bipolar Disord. 14, 478-487. doi: 10.1111/j.1399-5618.2012.01033.x
34. Gos, T., Schroeter, M. L., Lessel, W., Bernstein, H. G., Dobrowolny, H., Schiltz, K., et al. (2013). S100B-immunopositive astrocytes and oligodendrocytes in the hippocampus are differentially afflicted in unipolar and bipolar depression: a postmortem study. J. Psychiatr. Res. 47, 1694-1699. doi: 10.1016/j.jpsychires.2013.07.005
35. Gos, T., Steiner, J., Bielau, H., Dobrowoln, H., Günther, K., Mawrin, C., et al. (2012). Differences between unipolar and bipolar I depression in the quantitative analysis of glutamic acid decarboxylase-immunoreactive neuropil. Eur. Arch. Psychiatry Clin. Neurosci. 262, 647-655. doi: 10.1007/s00406-012-0315-x
36. Hamidi, M., Drevets, W. C., and Price, J. L. (2004). Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes. Biol. Psychiatry 55, 563-569. doi: 10.1016/j.biopsych.2003.11.006
37. Harrison, P. J. (2002). The neuropathology of primary mood disorder. Brain 125, 1428-1449. doi: 10.1093/brain/awf149
38. Hashioka, S., Miyaoka, T., Wake, R., Furuya, M., and Horiguchi, J. (2013). Glia: an important target for anti-inflammatory and antidepressant activity. Curr. Drug Targets 14, 1322-1328. doi: 10.2174/13894501113146660214
39. Hertz, L., Song, D., Li, B., Du, T., Xu, J., Gu, L., et al. (2014). Signal transduction in astrocytes during chronic or acute treatment with drugs (SSRIs, antibipolar Drugs, GABA-ergic drugs, and benzodiazepines) ameliorating mood disorders. J. Signal Transduct. 2014:593934. doi: 10.1155/2014/593934
40. Iwata, K., Café-Mendes, C. C., Schmitt, A., Steiner, J., Manabe, T., Matsuzaki, H., et al. (2013). The human oligodendrocyte proteome. Proteomics 13, 3548-3553. doi: 10.1002/pmic.201300201
41. Jayasundar, R., and Raghunathan, P. (1997). Evidence for left-right asymmetries in the proton MRS of brain in normal volunteers. Magn. Reson. Imaging 15, 223-234. doi: 10.1016/S0730-725X(96)00342-6
42. Kalkman, H. O. (2011). Circumstantial evidence for a role of glutamine-synthetase in suicide. Med. Hypotheses 76, 905-907. doi: 10.1016/j.mehy.2011.03.005
43. Kato, T. A., Watabe, M., and Kanba, S. (2013). Neuron-glia interaction as a possible glue to translate the mind-brain gap: a novel multi-dimensional approach toward psychology and psychiatry. Front. Psychiatry 4:139. doi: 10.3389/fpsyt.2013.00139
44. Katsel, P., Byne, W., Roussos, P., Tan, W., Siever, L., and Haroutunian, V. (2011). Astrocyte and glutamate markers in the superficial, deep and white matter layers of the anterior cingulate gyrus in schizophrenia. Neuropsychopharmacology 36, 1171-1177. doi: 10.1038/npp.2010.252
45. Kim, S., Choi, K. H., Baykiz, A. F., and Gershenfeld, H. K. (2007). Suicide candidate genes associated with bipolar disorder and schizophrenia: an exploratory gene expression profiling analysis of post-mortem prefrontal cortex. BMC Genomics 8:413. doi: 10.1186/1471-2164-8-413
46. Liu, Z., Song, D., Yan, E., Verkhratsky, A., and Peng, L. (2015). Chronic treatment with anti-bipolar drugs suppresses glutamate release from astroglial cultures. Amino Acids 47, 1045-1051. doi: 10.1007/s00726-015-1936-y
47. Luykx, J. J., Laban, K. G., van den Heuvel, M. P., Boks, M. P., Mandl, R. C., Kahn, R. S., et al. (2012). Region and state specific glutamate downregulation in major depressive disorder: a meta-analysis of (1)H-MRS findings. Neurosci. Biobehav. Rev. 36, 198-205. doi: 10.1016/j.neubiorev.2011.05.014
48. Mai, J. K., Paxinos, G., and Assheuer, J. K. (2003). Atlas of the Human Brain. Amsterdam: Elsevier Academic Press.
49. Malchow, B., Strocka, S., Frank, F., Bernstein, H. G., Steiner, J., Schneider-Axmann, T., et al. (2014). Stereological investigation of the posterior hippocampus in affective disorders. J. Neural Transm. doi: 10.1007/s00702-014-1316-x [Epub ahead of print].
50. Maletic, V., and Raison, C. (2014). Integrated neurobiology of bipolar disorder. Front. Psychiatry 5:98. doi: 10.3389/fpsyt.2014.00098
51. Manji, H. K., Drevets, W. C., and Charney, D. S. (2001). The cellular neurobiology of depression. Nat. Med. 7, 541-547. doi: 10.1038/87865
52. Martins-de-Souza, D., Schmitt, A., Röder, R., Lebar, M., Schneider-Axmann, T., Falkai, P., et al. (2010). Sex-specific proteome differences in the anterior cingulate cortex of schizophrenia. J. Psychiatr. Res. 44, 989-991. doi: 10.1016/j.jpsychires.2010.03.003
53. Miguel-Hidalgo, J. J., Waltzer, R., Whittom, A. A., Austin, M. C., Rajkowska, G., and Stockmeier, C. A. (2010). Glial and glutamatergic markers in depression, alcoholism, and their comorbidity. J. Affect. Disord. 127, 230-240. doi: 10.1016/j.jad.2010.06.003
54. Mitterauer, B. J. (2015). Balancing and imbalancing effects of astrocytic receptors in tripartite synapses. Common pathophysiological model of mental disorders and epilepsy. Med. Hypotheses 84, 315-320. doi: 10.1016/j.mehy.2015.01.025
55. Mosebach, J., Keilhoff, G., Gos, T., Schiltz, K., Schoeneck, L., Dobrowolny, H., et al. (2013). Increased nuclear Olig1-expression in the pregenual anterior cingulate white matter of patients with major depression: a regenerative attempt to compensate oligodendrocyte loss? J. Psychiatr. Res. 47, 1069-1079. doi: 10.1016/j.jpsychires.2013.03.018
56. Öngür, D., Drevets, W. C., and Price, J. L. (1998). Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc. Natl. Acad. Sci. U.S.A. 95, 13290-13295. doi: 10.1073/pnas.95.22.13290
57. Pehrson, A. L., and Sanchez, C. (2015). Altered γ-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressants. Drug Des. Devel. Ther. 9, 603-624. doi: 10.2147/DDDT.S62912
58. Pfleiderer, B., Michael, N., Erfurth, A., Ohrmann, P., Hohmann, U., Wolgast, M., et al. (2003). Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients. Psychiatry Res. 122, 185-192. doi: 10.1016/S0925-4927(03)00003-9
59. Rajkowska, G. (2000). Dysfunction in neural circuits involved in the pathophysiology of mood disorders: postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol. Psychiatry 48, 766-777. doi: 10.1016/S0006-3223(00)00950-1
60. Rajkowska, G. (2002). Cell pathology in mood disorders. Semin. Clin. Neuropsychiatry 7, 281-292. doi: 10.1053/scnp.2002.35228
61. Rajkowska, G., and Miguel-Hidalgo, J. J. (2007). Gliogenesis and glial pathology in depression. CNS Neurol. Disord. Drug Targets 6, 219-233. doi: 10.2174/187152707780619326
62. Rajkowska, G., and Stockmeier, C. A. (2013). Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue. Curr. Drug Targets 14, 1225-1236. doi: 10.2174/13894501113149990156
63. Rowland, L. M., Kontson, K., West, J., Edden, R. A., Zhu, H., Wijtenburg, S. A., et al. (2013). In vivo measurements of glutamate, GABA, and NAAG in schizophrenia. Schizophr. Bull. 39, 1096-1104. doi: 10.1093/schbul/sbs092
64. Sahlender, D. A., Savtchouk, I., and Volterra, A. (2014). What do we know about gliotransmitter release from astrocytes?Philos. Trans. R. Soc. Lond. B Biol. Sci. 369:20130592. doi: 10.1098/rstb.2013.0592
65. Salvadore, G., van der Veen, J. W., Zhang, Y., Marenco, S., Machado-Vieira, R., Baumann, J., et al. (2012). An investigation of amino-acid neurotransmitters as potential predictors of clinical improvement to ketamine in depression. Int. J. Neuropsychopharmacol. 15, 1063-1072. doi: 10.1017/S1461145711001593
66. Savitz, J. B., Price, J. L., and Drevets, W. C. (2014). Neuropathological and neuromorphometric abnormalities in bipolar disorder: view from the medial prefrontal cortical network. Neurosci. Biobehav. Rev. 42, 132-147. doi: 10.1016/j.neubiorev.2014.02.008
67. Schitine, C., Nogaroli, L., Costa, M. R., and Hedin-Pereira, C. (2015). Astrocyte heterogeneity in the brain: from development to disease. Front. Cell. Neurosci. 9:76. doi: 10.3389/fncel.2015.00076
68. Schroeter, M. L., Steiner, J., Schönknecht, P., and Mueller, K. (2014). Further evidence for a role of S100B in mood disorders: a human gene expression mega-analysis. J. Psychiatr. Res. 53, 84-86. doi: 10.1016/j.jpsychires.2014.02.021
69. Sequeira, A., Mamdani, F., Ernst, C., Vawter, M. P., Bunney, W. E., Lebel, V., et al. (2009). Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression. PLoS ONE 4:e6585. doi: 10.1371/journal.pone.0006585
70. Shende, V. H., McArthur, S., Gillies, G. E., and Opacka-Juffry, J. (2015). Astroglial plasticity is implicated in hippocampal remodelling in adult rats exposed to antenatal dexamethasone. Neural Plast. (in press). doi: 10.1155/2015/694347
71. Si, X., Miguel-Hidalgo, J. J., O'Dwyer, G., Stockmeier, C. A., and Rajkowska, G. (2004). Age-dependent reductions in the level of glial fibrillary acidic protein in the prefrontal cortex in major depression. Neuropsychopharmacology 29, 2088-2096. doi: 10.1038/sj.npp.1300525
72. Skolnick, P., Popik, P., and Trullas, R. (2009). Glutamate-based antidepressants: 20 years on. Trends Pharmacol. Sci. 30, 563-569. doi: 10.1016/j.tips.2009.09.002
73. Sofroniew, M. V., and Vinters, H. V. (2010). Astrocytes: biology and pathology. Acta Neuropathol. 119, 7-35. doi: 10.1007/s00401-009-0619-8
74. Steiner, J., Bogerts, B., Sarnyai, Z., Walter, M., Gos, T., Bernstein, H. G., et al. (2012). Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: potential role of glial NMDA receptor modulators and impaired blood-brain barrier integrity. World J. Biol. Psychiatry 13, 482-492. doi: 10.3109/15622975.2011.583941
75. Takasaki, C., Yamasaki, M., Uchigashima, M., Konno, K., Yanagawa, Y., and Watanabe, M. (2010). Cytochemical and cytological properties of perineuronal oligodendrocytes in the mouse cortex. Eur. J. Neurosci. 32, 1326-1336. doi: 10.1111/j.1460-9568.2010.07377.x
76. Teschemacher, A. G., Gourine, A. V., and Kasparov, S. (2015). A role for astrocytes in sensing the brain microenvironment and neuro-metabolic integration. Neurochem. Res. doi: 10.1007/s11064-015-1562-9 [Epub ahead of print]
77. Thompson, S. M., Kallarackal, A. J., Kvarta, M. D., Van Dyke, A. M., LeGates, T. A., and Cai, X. (2015). An excitatory synapse hypothesis of depression. Trends Neurosci. 38, 279-294. doi: 10.1016/j.tins.2015.03.003
78. Toro, C. T., Hallak, J. E., Dunham, J. S., and Deakin, J. F. (2006). Glial fibrillary acidic protein and glutamine synthetase in subregions of prefrontal cortex in schizophrenia and mood disorder. Neurosci. Lett. 404, 276-281. doi: 10.1016/j.neulet.2006.05.067
79. Uranova, N. A., Vostrikov, V. M., Orlovskaya, D. D., and Rachmanova, V. I. (2004). Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr. Res. 67, 269-275. doi: 10.1016/S0920-9964(03)00181-6
80. Van Horn, M. R., Sild, M., and Ruthazer, E. S. (2013). D-serine as a gliotransmitter and its roles in brain development and disease. Front. Cell. Neurosci. 7:39. doi: 10.3389/fncel.2013.00039
81. Verkhratsky, A., Rodríguez, J. J., and Steardo, L. (2014). Astrogliopathology: a central element of neuropsychiatric diseases?Neuroscientist 20, 576-588. doi: 10.1177/1073858413510208
82. Vostrikov, V. M., Uranova, N. A., and Orlovskaya, D. D. (2007). Deficit of perineuronal oligodendrocytes in the prefrontal cortex in schizophrenia and mood disorders. Schizophr. Res. 94, 273-280. doi: 10.1016/j.schres.2007.04.014
83. Walter, M., Henning, A., Grimm, S., Schulte, R. F., Beck, J., Dydak, U., et al. (2009). The relationship between aberrant neuronal activation in the pregenual anterior cingulate, altered glutamatergic metabolism, and anhedonia in major depression.Arch. Gen. Psychiatry 66, 478-486. doi: 10.1001/archgenpsychiatry.2009.39
84. Xu, J., Dydak, U., Harezlak, J., Nixon, J., Dzemidzic, M., Gunn, A. D., et al. (2013). Neurochemical abnormalities in unmedicated bipolar depression and mania: a 2D 1H MRS investigation. Psychiatry Res. 30, 235-241. doi: 10.1016/j.pscychresns.2013.02.008
85. Yüksel, C., and Öngür, D. (2010). Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders. Biol. Psychiatry 68, 785-794. doi: 10.1016/j.biopsych.2010.06.016